Brain Injury, Acute Clinical Trial
— HOACOfficial title:
HOAC: Improving Health Outcomes for Acute Concussion Patients
The primary purpose of this prospective observational trial is to validate the Brain Gauge
device as an objective tool for concussion assessment and treatment in order to determine if
a method that has proven successful in 18-22 year old collegiate student-athletes will be
applicable for military personnel. Overall aims of the study include:
1. Demonstration that the Brain Gauge can objectively measure concussion in this population
and thus improve concussion identification and coding.
2. Demonstration of stronger screening for and tracking of acute concussion and
documentation of concussion diagnoses, including improved tracking of recovery and
greater adherence to DOD/VA Clinical Practice Guidelines for acute concussion.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | June 30, 2020 |
Est. primary completion date | January 10, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria - Active duty military aged 18-60 stationed within local catchment area. - Confirmed concussion within the last 72 hours Exclusion Criteria - a sensory, motor or central neurological disorder such as seizures, ADD/ADHD, autism or neuropathy in the hands. - Subtest test records incomplete for key variables such as symptom report inventories. - Current MEB in process. - Pregnant women as there are parts of the Clinical practice guide that cannot be implemented as a part of standard clinical care due to pregnancy. |
Country | Name | City | State |
---|---|---|---|
Germany | Landstuhl Regional Medical Center | Landstuhl | Rheinland Pfalz |
Lead Sponsor | Collaborator |
---|---|
Kendra Jorgensen-Wagers | The Defense and Veterans Brain Injury Center |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Validate Brain Gauge to detect clinical/ statistically significant change in reaction time, reaction time variability, temporal order judgment, accuracy,fatigue and stimulus discrimination between concussed and healthy controls.. | The Brain Gauge is a health assessment system that takes advantage of the relationship between the sensory nerves in the fingers and the projection of those nerves to the corresponding regions in the brain. The system is composed of a mouse sized test device that uses novel fingertip vibration patterns to probe cortical connectivity and utilize that connectivity to gain more sensitive and specific detection of neural function. In sports concussion studies using this technology has established efficacy for detecting mild traumatic brain injury and tracking its recovery for differentiating individuals with and without traumatic brain injury with no baseline measures required. | 90 days | |
Secondary | Examine utility of remote telehealth clinical oversight for TBI recovery to improve accountability, and responsibilities for tracking concussion recovery | Prove efficacy of assessment via remote capability with synchronous and asynchronous Telehealth clinical oversight from TBI trained staff. This trial utilizes a symptom tracking application that patients can deploy on their own phones and complete the neurobehavioral symptom inventory. Mild traumatic brain injuries are difficult to diagnose or assess and are particularly difficult to assess in circumstances were triage decisions are necessary. Use of the Brain Gauge device as well as a patient centered commercial off the shelf software is hypothesized to not only increase patient compliance in treatment but also significantly personalize treatment to foster stronger recovery. | over the course of a year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03004976 -
Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke
|
Phase 2 |